Published in Neurorehabil Neural Repair on September 01, 2002
Rehabilitation robotics: pilot trial of a spatial extension for MIT-Manus. J Neuroeng Rehabil (2004) 2.31
Robotic neurorehabilitation: a computational motor learning perspective. J Neuroeng Rehabil (2009) 1.95
Intensive sensorimotor arm training mediated by therapist or robot improves hemiparesis in patients with chronic stroke. Neurorehabil Neural Repair (2008) 1.54
Kinematic robot-based evaluation scales and clinical counterparts to measure upper limb motor performance in patients with chronic stroke. Neurorehabil Neural Repair (2009) 1.47
Assessment of movement quality in robot- assisted upper limb rehabilitation after stroke: a review. J Neuroeng Rehabil (2014) 1.11
Therapeutic Robotics: A Technology Push: Stroke rehabilitation is being aided by robots that guide movement of shoulders and elbows, wrists, hands, arms and ankles to significantly improve recovery of patients. Proc IEEE Inst Electr Electron Eng (2006) 0.87
Effects of the Alternate Combination of "Error-Enhancing" and "Active Assistive" Robot-Mediated Treatments on Stroke Patients. IEEE J Transl Eng Health Med (2013) 0.75
Longitudinal Assessment of Motor Recovery of Contralateral Hand after Basal Ganglia Infarction Using Functional Magnetic Resonance Imaging. Biomed Res Int (2016) 0.75
The coordination of arm movements: an experimentally confirmed mathematical model. J Neurosci (1985) 8.13
Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med (2010) 6.21
Cognition and immunity; antibody impairs memory. Immunity (2004) 3.40
Robot-aided neurorehabilitation. IEEE Trans Rehabil Eng (1998) 3.34
Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A (2006) 2.97
The mechanics of multi-joint posture and movement control. Biol Cybern (1985) 2.91
Movement smoothness changes during stroke recovery. J Neurosci (2002) 2.83
An organizing principle for a class of voluntary movements. J Neurosci (1984) 2.80
Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol (2009) 2.70
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
The effect of robot-assisted therapy and rehabilitative training on motor recovery following stroke. Arch Neurol (1997) 2.50
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther (2008) 2.42
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol (2008) 2.40
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS One (2012) 2.40
Rehabilitation robotics: pilot trial of a spatial extension for MIT-Manus. J Neuroeng Rehabil (2004) 2.31
A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation. Neurology (2000) 2.22
Neural, mechanical, and geometric factors subserving arm posture in humans. J Neurosci (1985) 2.18
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma. N Engl J Med (2015) 2.10
Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol (2003) 2.06
Robot-aided sensorimotor arm training improves outcome in patients with chronic stroke. Neurology (2003) 2.03
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg (2014) 2.03
Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science (2004) 2.00
Female mouse fetal loss mediated by maternal autoantibody. J Exp Med (2012) 1.92
Changing motor synergies in chronic stroke. J Neurophysiol (2007) 1.77
Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol (2006) 1.74
Quantization of continuous arm movements in humans with brain injury. Proc Natl Acad Sci U S A (1999) 1.73
Is robot-aided sensorimotor training in stroke rehabilitation a realistic option? Curr Opin Neurol (2001) 1.72
XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development. J Exp Med (2009) 1.71
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg (2008) 1.67
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leuk Lymphoma (2007) 1.66
Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. Proc Natl Acad Sci U S A (2011) 1.66
Robot training enhanced motor outcome in patients with stroke maintained over 3 years. Neurology (1999) 1.65
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A (2010) 1.65
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg (2011) 1.62
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy. Ann Oncol (2007) 1.58
Robot-aided neurorehabilitation: a robot for wrist rehabilitation. IEEE Trans Neural Syst Rehabil Eng (2007) 1.57
Increasing productivity and quality of care: robot-aided neuro-rehabilitation. J Rehabil Res Dev (2001) 1.57
Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol (2002) 1.56
Customized interactive robotic treatment for stroke: EMG-triggered therapy. IEEE Trans Neural Syst Rehabil Eng (2005) 1.56
Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med (2008) 1.54
Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol (2009) 1.52
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res (2013) 1.51
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors. Cancer Immun (2007) 1.46
Submovements grow larger, fewer, and more blended during stroke recovery. Motor Control (2004) 1.44
Motions or muscles? Some behavioral factors underlying robotic assistance of motor recovery. J Rehabil Res Dev (2006) 1.40
An economic analysis of robot-assisted therapy for long-term upper-limb impairment after stroke. Stroke (2011) 1.37
Treatment interventions for the paretic upper limb of stroke survivors: a critical review. Neurorehabil Neural Repair (2003) 1.36
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer (2006) 1.36
HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med (2012) 1.33
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res (2003) 1.32
Intermittency in preplanned elbow movements persists in the absence of visual feedback. J Neurophysiol (1998) 1.26
Does the nervous system use equilibrium-point control to guide single and multiple joint movements? Behav Brain Sci (1992) 1.25
Design and Characterization of Hand Module for Whole-Arm Rehabilitation Following Stroke. IEEE ASME Trans Mechatron (2007) 1.22
Posture control and trajectory formation during arm movement. J Neurosci (1984) 1.21
Robot-aided neurorehabilitation: from evidence-based to science-based rehabilitation. Top Stroke Rehabil (2002) 1.21
Procedural motor learning in Parkinson's disease. Exp Brain Res (2001) 1.20
Raised corticomotor excitability of M1 forearm area following anodal tDCS is sustained during robotic wrist therapy in chronic stroke. Restor Neurol Neurosci (2009) 1.20
Probability density of the surface electromyogram and its relation to amplitude detectors. IEEE Trans Biomed Eng (1999) 1.20
A review of the methods of processing EMG for use as a proportional control signal. Biomed Eng (1976) 1.18
Submovement changes characterize generalization of motor recovery after stroke. Cortex (2008) 1.18
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. J Neurosurg (2010) 1.15
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun (2009) 1.15
Transcranial magnetic stimulation, synaptic plasticity and network oscillations. J Neuroeng Rehabil (2009) 1.14
Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg (2011) 1.12
Modulation and vectorial summation of the spinalized frog's hindlimb end-point force produced by intraspinal electrical stimulation of the cord. IEEE Trans Neural Syst Rehabil Eng (2001) 1.11
Arm trajectory formation in monkeys. Exp Brain Res (1982) 1.11
Overview of clinical trials with MIT-MANUS: a robot-aided neuro-rehabilitation facility. Technol Health Care (1999) 1.11
Reversal of thiamine deficiency-induced neurodegeneration. J Neuropathol Exp Neurol (2003) 1.10
Continuous passive motion improves shoulder joint integrity following stroke. Clin Rehabil (2005) 1.09
Differentiation of the dopaminergic phenotype in the olfactory system of neonatal and adult mice. J Comp Neurol (2004) 1.08
Controlling multijoint motor behavior. Exerc Sport Sci Rev (1987) 1.06
Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery. Stroke (2013) 1.05
Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera. Haematologica (2011) 1.05
Myoelectric signal processing: optimal estimation applied to electromyography--Part I: derivation of the optimal myoprocessor. IEEE Trans Biomed Eng (1980) 1.04
Robotics and other devices in the treatment of patients recovering from stroke. Curr Neurol Neurosci Rep (2005) 1.03
Cognitively impaired stroke patients do benefit from admission to an acute rehabilitation unit. Arch Phys Med Rehabil (2008) 1.03
Learning, not adaptation, characterizes stroke motor recovery: evidence from kinematic changes induced by robot-assisted therapy in trained and untrained task in the same workspace. IEEE Trans Neural Syst Rehabil Eng (2011) 1.01
Stability in force-production tasks. J Mot Behav (2001) 1.01
Relating agonist-antagonist electromyograms to joint torque during isometric, quasi-isotonic, nonfatiguing contractions. IEEE Trans Biomed Eng (1997) 1.00
Robot-aided functional imaging: application to a motor learning study. Hum Brain Mapp (1998) 0.99
The influence of age on weight-bearing joint reposition sense of the knee. Exp Brain Res (2001) 0.99
Does shorter rehabilitation limit potential recovery poststroke? Neurorehabil Neural Repair (2004) 0.98
Stability properties of human reaching movements. Exp Brain Res (1995) 0.97
Stochastic estimation of arm mechanical impedance during robotic stroke rehabilitation. IEEE Trans Neural Syst Rehabil Eng (2007) 0.97
Haptic interaction with virtual objects. Spatial perception and motor control. Biol Cybern (2000) 0.97
Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. J Nerv Ment Dis (2008) 0.97
Solving interpersonal problems correlates with symptom improvement in interpersonal psychotherapy: preliminary findings. J Nerv Ment Dis (2006) 0.96
Saccadic palsy after cardiac surgery: visual disability and rehabilitation. Ann N Y Acad Sci (2002) 0.94
Multicenter randomized trial of robot-assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICS. Neurorehabil Neural Repair (2009) 0.94
Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression. Cancer (2006) 0.93
Increased PTH and 1.25(OH)(2)D levels associated with increased markers of bone turnover following bariatric surgery. Obesity (Silver Spring) (2011) 0.93